Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Lung Cancer

  Free Subscription


11.08.2025

1 AJR Am J Roentgenol
2 Ann Surg Oncol
2 Anticancer Res
1 BMC Cancer
1 Cancer
1 Cancer Lett
4 Cancer Sci
1 Clin Exp Metastasis
2 Clin Lung Cancer
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Clin Invest
1 J Thorac Cardiovasc Surg
6 J Thorac Oncol
5 Lung Cancer
1 Oncogene
1 Oncol Rep
2 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. BALBI M, Ledda RE, Milanese G, Ruggirello M, et al
    Characteristics and Outcomes of Lung-RADS Version 2022 Atypical Pulmonary Cysts With Ground-Glass Components on Lung Cancer Screening CT: Secondary Analysis of BioMILD Trial Data.
    AJR Am J Roentgenol. 2025 Aug 6. doi: 10.2214/AJR.25.33427.
    PubMed        


    Ann Surg Oncol

  2. CHENG JJ, Dai ZY, Wang FQ, Zhang HL, et al
    ASO Author Reflections: Leveraging Individual Patient Data to Refining Surgical Decision Making in Spread Through Air Spaces: Positive Stage I Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17995.
    PubMed        

  3. SUN J, Shen Z, Han L, Wan S, et al
    The Prognostic Significance of SMARCA4 Deficiency in Early-Stage Pulmonary Large Cell Carcinoma.
    Ann Surg Oncol. 2025;32:7049-7058.
    PubMed         Abstract available


    Anticancer Res

  4. KOH JW, Park SJ
    Down-regulation of SMPDL3B Inhibits the Proliferation, Migration, and Invasion of Lung Adenocarcinoma Cells.
    Anticancer Res. 2025;45:3275-3286.
    PubMed         Abstract available

  5. RADES D, Doehring L, Delikanli C, Groh EM, et al
    Estimating the Risk of Radiation Pneumonitis in Elderly Patients With Lung Cancer.
    Anticancer Res. 2025;45:3347-3353.
    PubMed         Abstract available


    BMC Cancer

  6. PENG Z, Wang Y, Qi Y, Hu H, et al
    Application of prediction model based on CT radiomics in prognosis of patients with non-small cell lung cancer.
    BMC Cancer. 2025;25:1273.
    PubMed         Abstract available


    Cancer

  7. NIERENGARTEN MB
    Effective and efficient large-scale lung cancer screening: Low-dose computed tomography screening for lung cancer enables early diagnosis in asymptomatic, high-risk individuals and has been shown to reduce lung cancer-related mortality.
    Cancer. 2025;131:e35956.
    PubMed        


    Cancer Lett

  8. MA G, Wang D, Deng Y, Huang W, et al
    Targeting activation of intrinsic apoptotic pathway through Mcl-1 inhibition to delay emergence of acquired resistance of lung cancer to osimertinib.
    Cancer Lett. 2025;632:217962.
    PubMed         Abstract available


    Cancer Sci

  9. WEI T, Cheng Y, Ge J, Zhu M, et al
    The Pro-Apoptotic Effect of Glucose Restriction in NSCLC via AMPK-Regulated Circadian Clock Gene Bmal1.
    Cancer Sci. 2025;116:2101-2112.
    PubMed         Abstract available

  10. KIJIMA T, Kato T, Goto Y, Kuribayashi K, et al
    KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin-Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma.
    Cancer Sci. 2025;116:2208-2217.
    PubMed         Abstract available

  11. YOKOYAMA T, Saitoh M, Miyazawa K
    TGF-beta Enhances Doxorubicin Resistance and Anchorage-Independent Growth in Cancer Cells by Inducing ALDH1A1 Expression.
    Cancer Sci. 2025;116:2176-2188.
    PubMed         Abstract available

  12. MO X, He J, Shen X, Li C, et al
    Connexin43 Promotes the Invasion and Metastasis of Lung Squamous Cell Carcinoma via GJIC-Dependent Ca(2+)/ERK Signaling Activation.
    Cancer Sci. 2025;116:2086-2100.
    PubMed         Abstract available


    Clin Exp Metastasis

  13. CHENG L, Li S, Cui Z, Sun X, et al
    G-protein coupled receptor 183 (GPR183) inhibits visceral metastasis of non-small cell lung cancer.
    Clin Exp Metastasis. 2025;42:44.
    PubMed         Abstract available


    Clin Lung Cancer

  14. BLOCH Z, Jensen S, Sorensen V, Langer SW, et al
    The Effect of Exercise on Quality of Life in Patients With Advanced Lung Cancer: A Secondary Analysis of a Randomized Controlled Trial.
    Clin Lung Cancer. 2025 Jul 9:S1525-7304(25)00149.
    PubMed         Abstract available

  15. KALKHORAN HA, Verschueren MV, Peters BJM, van de Garde EMW, et al
    Real World Effectiveness of Durvalumab in Stage III Unresectable Non-small Cell Lung Cancer: What is the Role of PD-L1 Expression?
    Clin Lung Cancer. 2025 Jul 17:S1525-7304(25)00154.
    PubMed         Abstract available


    Int J Cancer

  16. LI W, Pan S, Qian J, Xia Y, et al
    Comparisons of blood, upper respiratory tract and gut viromes from patients with lung cancer and healthy persons.
    Int J Cancer. 2025 Aug 8. doi: 10.1002/ijc.70075.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  17. MONTI S, Giuseppe P, Caroprese M, Cella L, et al
    External Validation of Dose Patterns and Dosimetric Predictors for Radiation-Induced Esophagitis in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06043.
    PubMed         Abstract available


    J Clin Invest

  18. XIONG T, Wang G, Yu P, Li Z, et al
    CAR-T cells targeting CD155 reduce tumor burden in preclinical models of leukemia and solid tumors.
    J Clin Invest. 2025;135:e189920.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  19. PARIKH MJ, Russo MG, Tompkins AK, Erkmen CP, et al
    Reply: Multilevel bridge to lung cancer screening adherence.
    J Thorac Cardiovasc Surg. 2025 Aug 7:S0022-5223(25)00559.
    PubMed        


    J Thorac Oncol

  20. ZHANG B, Shah KB, Parma M, Wang K, et al
    Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC-A Real-World Case Series: Case Report.
    J Thorac Oncol. 2025;20:1131-1138.
    PubMed         Abstract available

  21. NAKAZAWA S, Pecci F, Ricciuti B, Gottlieb FH, et al
    Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC.
    J Thorac Oncol. 2025;20:1035-1049.
    PubMed         Abstract available

  22. JANNE PA, Goto Y, Kubo T, Ninomiya K, et al
    Final analysis results and patient-reported outcomes from DESTINY-Lung02-a dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic non-small cell lung cancer.
    J Thorac Oncol. 2025 Jul 30:S1556-0864(25)00981.
    PubMed         Abstract available

  23. BANERJEE A, Vathiotis I, Halder D, Sen U, et al
    Molecular Landscape and Therapeutic Strategies of Lung Cancer Lineage Plasticity.
    J Thorac Oncol. 2025 Aug 2:S1556-0864(25)00773.
    PubMed         Abstract available

  24. HERBST RS, Prizant H, Ruderman D, Conway J, et al
    Digital Versus Manual PD-L1 Scoring in Advanced Non-Small Cell Lung Cancer From the IMpower110 and IMpower150 Trials.
    J Thorac Oncol. 2025 Aug 2:S1556-0864(25)00983.
    PubMed         Abstract available

  25. AL-RABI K, El Khatib O, Abdeljalil R, Talab Y, et al
    Lung Cancer in Jordan.
    J Thorac Oncol. 2025;20:1007-1017.
    PubMed        


    Lung Cancer

  26. ZENG L, Tong F, Xu X, Song L, et al
    Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancer.
    Lung Cancer. 2025;207:108684.
    PubMed         Abstract available

  27. LIU G, Liu Y, Jing H, Chen T, et al
    Global, regional, and national economic consequences of tracheal, bronchial, and lung cancer.
    Lung Cancer. 2025;207:108685.
    PubMed         Abstract available

  28. ZHANG Y, Zhao J, Ma Z, Yi J, et al
    Immune checkpoint inhibitors for advanced non-small cell lung cancer with preexisting COPD and CT-defined emphysema: A systematic review and meta-analysis.
    Lung Cancer. 2025;207:108700.
    PubMed         Abstract available

  29. GRONBERG M, Aanerud M, Halvorsen TO, Killingberg KT, et al
    Associations between progastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) and survival in patients with limited-stage small cell lung cancer (LS SCLC) receiving chemoradiotherapy (CRT).
    Lung Cancer. 2025;207:108678.
    PubMed         Abstract available

  30. DINGEMANS AC, Syrigos K, Livi L, Paulus A, et al
    Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial.
    Lung Cancer. 2025;207:108683.
    PubMed         Abstract available


    Oncogene

  31. SHI R, Farnsworth DA, Febres-Aldana CA, Chow JLM, et al
    Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.
    Oncogene. 2025;44:2831-2849.
    PubMed         Abstract available


    Oncol Rep

  32. FUJIYOSHI K, Sugihara R, Miyamoto N, Watanabe Y, et al
    Comprehensive genetic profiling using tissue and blood in locally advanced tumors.
    Oncol Rep. 2025;54:134.
    PubMed         Abstract available


    PLoS One

  33. KHAN AH, Li J, Asghar MN, Iqbal S, et al
    LGD_Net: Capsule network with extreme learning machine for classification of lung diseases using CT scans.
    PLoS One. 2025;20:e0327419.
    PubMed         Abstract available

  34. OCHI T, Sakairi Y, Sata Y, Toyoda T, et al
    Indocyanine green intravenous administration can more accurately identify the intersegmental plane than the inflation-deflation method in lung segmentectomy.
    PLoS One. 2025;20:e0328362.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.